Non-small cell lung cancer (NSCLC) is the most common form of lung cancer and it is often found with activating mutations in the KRAS oncogene which causes the tumor cells to be aggressive and resistant to chemotherapy [3]–[5]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.